CORT Logo

Corcept Therapeutics Incorporated (CORT) 

NASDAQ
Market Cap
$6.25B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
619 of 966
Rank in Industry
341 of 554

Largest Insider Buys in Sector

CORT Stock Price History Chart

CORT Stock Performance

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.

Insider Activity of Corcept Therapeutics Incorporated

Over the last 12 months, insiders at Corcept Therapeutics Incorporated have bought $0 and sold $9.63M worth of Corcept Therapeutics Incorporated stock.

On average, over the past 5 years, insiders at Corcept Therapeutics Incorporated have bought $2.34M and sold $8.44M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 150,000 shares for transaction amount of $3.23M was made by BAKER G LEONARD JR (director) on 2021‑06‑11.

List of Insider Buy and Sell Transactions, Corcept Therapeutics Incorporated

2024-11-22SaleChief Business Officer
2,609
0.0024%
$56.20$146,626+2.90%
2024-11-22SaleSee Remarks
1,411
0.0013%
$56.72$80,032+2.90%
2024-11-11Saledirector
2,200
0.0021%
$59.88$131,736-0.81%
2024-11-04SaleChief Development Officer
3,394
0.0032%
$48.97$166,204+17.02%
2024-10-01SaleChief Business Officer
11,000
0.0113%
$46.28$509,080+8.97%
2024-10-01SaleChief Development Officer
10,000
0.0102%
$46.28$462,800+8.97%
2024-09-03SaleChief Development Officer
10,000
0.0099%
$35.30$353,000+37.27%
2024-08-26SaleChief Business Officer
3,101
0.003%
$35.71$110,737+33.57%
2024-08-01SaleChief Development Officer
10,000
0.0098%
$38.67$386,700+19.57%
2024-08-01Saledirector
150
0.0001%
$38.50$5,775+19.57%
2024-07-01SaleChief Business Officer
11,000
0.0109%
$32.49$357,3900.00%
2024-07-01SaleSee Remarks
5,000
0.0049%
$32.49$162,4520.00%
2024-07-01SaleChief Development Officer
10,000
0.0099%
$32.49$324,9000.00%
2024-07-01Saledirector
2,200
0.0022%
$32.81$72,1820.00%
2024-06-03SaleSee Remarks
5,000
0.0046%
$30.18$150,916+21.21%
2024-06-03SaleChief Development Officer
10,000
0.0098%
$32.00$320,000+21.21%
2024-06-03Saledirector
2,200
0.002%
$30.21$66,462+21.21%
2024-05-28SaleChief Business Officer
11,000
0.0102%
$30.39$334,294+12.97%
2024-05-28SaleChief Development Officer
30,000
0.0292%
$32.00$960,000+12.97%
2024-05-13SaleSee Remarks
50,000
0.0488%
$28.00$1.4M+27.24%

Insider Historical Profitability

18.52%
Maduck SeanSee Remarks
85222
0.0813%
$59.68026
Robb Gary CharlesChief Business Officer
20163
0.0192%
$59.68126+72.23%
Lyon Joseph DouglasSee Remarks
8494
0.0081%
$59.68022
Guyer WilliamChief Development Officer
5796
0.0055%
$59.6808
Swisher Daniel N JRdirector
0
0%
$59.68023
ALTA BIOPHARMA PARTNERS II LP10 percent owner
5484063
5.2341%
$59.6820+16.86%
PENHOET EDWARD
5484063
5.2341%
$59.6810+78.79%
SUTTER HILL VENTURES10 percent owner
5217464
4.9797%
$59.6860+59.94%
MARDUEL ALIX10 percent owner
5043299
4.8135%
$59.6830+59.16%
GAITHER JAMES C10 percent owner
4338742
4.141%
$59.6850+56.16%
Speiser Michael L10 percent owner
4338742
4.141%
$59.6810+13%
BAKER G LEONARD JRdirector
3308303
3.1575%
$59.68405+21.66%
BELANOFF JOSEPH KChief Executive Officer
2538218
2.4225%
$59.680101
SCHATZBERG ALAN Fdirector, 10 percent owner
2438749
2.3276%
$59.6811+197.78%
SINGER DAVID Bdirector
731667
0.6983%
$59.6802
YOUNGER WILLIAM H JR10 percent owner
575066
0.5489%
$59.6860+59.94%
COXE TENCH10 percent owner
360048
0.3436%
$59.6860+59.94%
ANDERSON DAVID L10 percent owner
289747
0.2765%
$59.6860+59.94%
COOK JOSEPH C JRdirector
241521
0.2305%
$59.68181+61.71%
ANDERSSON ALLENdirector
209694
0.2001%
$59.68468<0.0001%
Paperboy Ventures, LLCdirector
209694
0.2001%
$59.68466<0.0001%
Longitude Venture Partners L.P.10 percent owner
180103
0.1719%
$59.68316+27.2%
BRADBURY DANIELdirector
177925
0.1698%
$59.68412+44.97%
BIRD JEFFREY W10 percent owner
126252
0.1205%
$59.6860+59.94%
WHITE JAMES N10 percent owner
121117
0.1156%
$59.6860+59.94%
ENRIGHT PATRICK Gdirector
114675
0.1094%
$59.68323+27.2%
SANDS GREGORY P10 percent owner
109913
0.1049%
$59.6871+49.02%
Hunt HazelChief Scientific Officer
73146
0.0698%
$59.6801
Harper James Adirector
57900
0.0553%
$59.6860+81.34%
SWEET DAVID E10 percent owner
18480
0.0176%
$59.6860+59.94%
SHEEHAN ANDREW T10 percent owner
18325
0.0175%
$59.6840+17.87%
MAHONEY DAVID Ldirector
11297
0.0108%
$59.68129+42.33%
TURNER JOSEPH Ldirector
10000
0.0095%
$59.6820<0.0001%
GALA RENEE Ddirector
10000
0.0095%
$59.6820<0.0001%
KURLAND FREDChief Financial Officer
7500
0.0072%
$59.6820+11.49%
FISHMAN ROBERT SChief Medical Officer
0
0%
$59.68012
WILSON JAMES Ndirector
0
0%
$59.68428+50.46%
ROE ROBERT LPresident and Secretary
0
0%
$59.68073
Lo StevenVP Commercial Operations
0
0%
$59.6804

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$423.85M16.1616.83M+2.55%+$10.54M0.01
The Vanguard Group$240.96M9.199.57M+0.3%+$711,617.50<0.01
Ingalls Snyder Llc$209.16M7.988.3M-0.58%-$1.23M9.78
Renaissance Technologies$179.31M6.847.12M+5.84%+$9.89M0.29
Parallel Advisors, LLC$96.12M3.673.82M+1.26%+$1.19M2.62
State Street$90.07M3.433.58M+5.55%+$4.74M<0.01
Dimensional Fund Advisors$64.68M2.472.57M+11.14%+$6.48M0.02
Novo Holdings A/S$60.74M2.322.41M0%+$04.24
Geode Capital Management$54.36M2.072.16M+5.48%+$2.83M0.01
First Trust$46.32M1.771.84M+1,150.82%+$42.62M0.05
Boston Trust Walden Corp$46.23M1.761.84M-0.64%-$298,022.890.33
Arrowstreet Capital, Limited Partnership$42.49M1.621.69M+53.18%+$14.75M0.04
Morgan Stanley$38.11M1.451.51M+16.74%+$5.46M<0.01
Man Group Plc$37.76M1.441.5M+81.44%+$16.95M0.09
D. E. Shaw & Co.$28.54M1.091.13M-31.69%-$13.24M0.03
Voloridge Investment Management, LLC$26.03M0.991.03M+88.79%+$12.24M0.1
Northern Trust$24.27M0.93963,443-11.73%-$3.23M<0.01
Charles Schwab$23.51M0.9933,461+3.67%+$831,698.210.01
Fidelity Investments$21.47M0.82852,345+19.81%+$3.55M<0.01
Two Sigma$20.62M0.79818,475+71.39%+$8.59M0.03
Invesco$19.4M0.74770,280+13.79%+$2.35M<0.01
Two Sigma Advisers LP$19.15M0.73760,200+41.72%+$5.64M0.03
Jupiter Fund Management$18.75M0.72744,469+1,148.98%+$17.25M0.05
Jacobs Levy Equity Management$18.43M0.7731,468New+$18.43M0.07
BNY Mellon$18.24M0.7724,022-6.31%-$1.23M<0.01
Cerity Partners$17.02M0.65675,843+812.48%+$15.16M0.05
Bank of America$16.96M0.65673,354+134.29%+$9.72M<0.01
ClearBridge Investments$14.67M0.56582,355New+$14.67M0.01
Millennium Management LLC$13.93M0.53553,007-19.86%-$3.45M0.01
Connor Clark & Lunn Investment Management Ltd$13.66M0.52542,178+50.1%+$4.56M0.03
Goldman Sachs$10.95M0.42434,722-18.4%-$2.47M<0.01
Burney Wealth Management$10.87M0.42431,638+2.96%+$312,406.110.46
Cubist Systematic Strategies$8.85M0.34351,374+51.01%+$2.99M0.08
ROYCE & ASSOCIATES INC$8.47M0.32336,272+0.06%+$4,962.430.08
Cambridge Investment Research Advisors Inc$8.17M0.31324,271+2,922.66%+$7.9M0.03
Ameriprise Financial$7.38M0.28292,900+6.57%+$455,151.96<0.01
S&T Bank$7.32M0.28290,487-9.46%-$764,452.911.4
Barclays$6.93M0.26275,244+51.61%+$2.36M<0.01
Janus Henderson$6.68M0.26265,049+482.55%+$5.53M<0.01
Citadel Advisors LLC$6.66M0.25264,309-40.2%-$4.48M<0.01
AQR Capital$6.51M0.25258,408+182.62%+$4.21M0.01
Legal & General$6.36M0.24252,443+0.39%+$24,686.20<0.01
Franklin Templeton Investments$6.18M0.24245,462+7.86%+$450,321.65<0.01
Acadian Asset Management$5.94M0.23236,199-13.73%-$946,187.140.02
Nuveen$5.52M0.21219,037-16.84%-$1.12M<0.01
Engineers Gate Manager Lp$5.21M0.2206,751+1,744.34%+$4.93M0.12
RhumbLine Advisers$5.21M0.2206,744-2.61%-$139,778.660.01
Allianz Asset Management Gmbh$5.06M0.19200,893+311.51%+$3.83M0.01
AllianceBernstein$5.02M0.19199,354-18.46%-$1.14M<0.01
JPMorgan Chase$4.88M0.19193,571-3.01%-$151,467.49<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.